These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 30442831)

  • 1. Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality.
    Raimundo K; Solomon JJ; Olson AL; Kong AM; Cole AL; Fischer A; Swigris JJ
    J Rheumatol; 2019 Apr; 46(4):360-369. PubMed ID: 30442831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement.
    Fischer A; Kong AM; Swigris JJ; Cole AL; Raimundo K
    J Rheumatol; 2018 Feb; 45(2):235-241. PubMed ID: 29142033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.
    Hyldgaard C; Hilberg O; Pedersen AB; Ulrichsen SP; Løkke A; Bendstrup E; Ellingsen T
    Ann Rheum Dis; 2017 Oct; 76(10):1700-1706. PubMed ID: 28611082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of interstitial lung disease and mortality in rheumatoid arthritis.
    Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
    Rheumatology (Oxford); 2017 Mar; 56(3):344-350. PubMed ID: 27940586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients.
    Sparks JA; Jin Y; Cho SK; Vine S; Desai R; Doyle TJ; Kim SC
    Rheumatology (Oxford); 2021 Aug; 60(8):3689-3698. PubMed ID: 33462611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
    Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
    Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
    Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.
    Bongartz T; Nannini C; Medina-Velasquez YF; Achenbach SJ; Crowson CS; Ryu JH; Vassallo R; Gabriel SE; Matteson EL
    Arthritis Rheum; 2010 Jun; 62(6):1583-91. PubMed ID: 20155830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis.
    Kim D; Cho SK; Choi CB; Choe JY; Chung WT; Hong SJ; Jun JB; Jung YO; Kim TH; Kim TJ; Lee HS; Lee JH; Lee J; Lee SS; Yoo DH; Yoon BY; Song JW; Bae SC; Sung YK
    Rheumatol Int; 2017 Oct; 37(10):1735-1745. PubMed ID: 28748423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
    Solomon JJ; Ryu JH; Tazelaar HD; Myers JL; Tuder R; Cool CD; Curran-Everett D; Fischer A; Swigris JJ; Brown KK
    Respir Med; 2013 Aug; 107(8):1247-52. PubMed ID: 23791462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of claims-based algorithms to identify interstitial lung disease in patients with rheumatoid arthritis.
    Cho SK; Doyle TJ; Lee H; Jin Y; Tong AY; Ortiz AJS; Sparks JA; Kim SC
    Semin Arthritis Rheum; 2020 Aug; 50(4):592-597. PubMed ID: 32480097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Matrix Metalloproteinase Concentrations and Risk of Interstitial Lung Disease in a Prospective Rheumatoid Arthritis Cohort.
    Luedders BA; Wheeler AM; Ascherman DP; Baker JF; Duryee MJ; Yang Y; Roul P; Wysham KD; Monach P; Reimold A; Kerr GS; Kunkel G; Cannon GW; Poole JA; Thiele GM; Mikuls TR; England BR
    Arthritis Rheumatol; 2024 Jul; 76(7):1013-1022. PubMed ID: 38268499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease.
    Venkat RK; Hayashi K; Juge PA; McDermott G; Paudel M; Wang X; Vanni KMM; Kowalski EN; Qian G; Bade KJ; Saavedra AA; Mueller KT; Chang SH; Dellaripa PF; Weinblatt ME; Shadick NA; Doyle TJ; Dieude P; Sparks JA
    Clin Rheumatol; 2024 Aug; 43(8):2453-2466. PubMed ID: 38898318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
    Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
    Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid Arthritis-Associated Interstitial Lung Disease: Clinical Characteristics and Predictors of Mortality.
    Hyldgaard C; Ellingsen T; Hilberg O; Bendstrup E
    Respiration; 2019; 98(5):455-460. PubMed ID: 31597131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis.
    Singh N; Varghese J; England BR; Solomon JJ; Michaud K; Mikuls TR; Healy HS; Kimpston EM; Schweizer ML
    Semin Arthritis Rheum; 2019 Dec; 49(3):358-365. PubMed ID: 31153706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis-interstitial lung disease-associated mortality.
    Olson AL; Swigris JJ; Sprunger DB; Fischer A; Fernandez-Perez ER; Solomon J; Murphy J; Cohen M; Raghu G; Brown KK
    Am J Respir Crit Care Med; 2011 Feb; 183(3):372-8. PubMed ID: 20851924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.
    Yang JA; Lee JS; Park JK; Lee EB; Song YW; Lee EY
    Korean J Intern Med; 2019 Mar; 34(2):434-441. PubMed ID: 28352064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
    Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A;
    Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.